Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Debiopharm
Debiopharm
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Debiopharm
Total Funding
$2.1 M
Debiopharm Summary
Company Summary
Overview
Debiopharm is a biopharmaceutical company specializing in oncology and bacterial infections. Its main activities include drug development, drug manufacturing, and digital health investment.
Type
Private
Status
Active
Founded
1979
HQ
Lausanne, CH
|
view all locations
Website
https://www.debiopharm.com
Cybersecurity rating
Sectors
Healthcare
drug development
oncology
pharma
Homepage
Linkedin
instagram
facebook
youtube
twitter
Table of Contents
Key People
Locations
Competitors
Key People
Valérie Calvayrac,
Senior Vice President Asset Management
Cédric Sager,
Chief Executive Officer, Debiopharm Research & Manufacturing S.A.
Tanja Dowe,
CEO of Debiopharm Innovation Fund S.A.
Anne Marguerettaz,
Technical Operations Director, Debiopharm Research & Manufacturing S.A.
and 12 others
Locations
View all
2 locations detected
Lausanne, VD
HQ
Switzerland
Chemin Messidor 5/5911
Oss, NB
Netherlands
Kloosterstraat 9
Competitors and Similar Companies
TriSalus Life Sciences
Healthcare - Public
Sunshine Biopharma
Healthcare - Public
Turning Point Therapeutics
Healthcare - Subsidiary
Pyxis Oncology
Healthcare - Public
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top